To date, the underlying molecular mechanisms of LASS2 reported for HCC regulation remain poorly understood, and its role and mechanisms in other subtypes of liver cancer (such as CCA and HB) are also poorly reported. The gene discussed is CERS2; the disease is cholangiocarcinoma.